1. Status of Epstein-Barr Virus Coinfection with Helicobacter pylori in Gastric Cancer
    Shyam Singh et al, 2017, Journal of Oncology CrossRef
  2. Identification of Epstein-Barr Virus Replication Proteins in Burkitt’s Lymphoma Cells
    Chris Traylen et al, 2015, Pathogens CrossRef
  3. CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer
    Shu Su et al, 2017, OncoImmunology CrossRef
  4. Gastrin and Gastric Cancer
    Helge L. Waldum et al, 2017, Front. Endocrinol. CrossRef
  5. The Methylation Status and Expression of Epstein-Barr Virus Early Genes BARF1 and BHRF1 in Epstein-Barr Virus-Associated Gastric Carcinomas
    Jing Li et al, 2017, Gastroenterology Research and Practice CrossRef
  6. Role of Viral miRNAs and Epigenetic Modifications in Epstein-Barr Virus-Associated Gastric Carcinogenesis
    Aldo Giudice et al, 2016, Oxidative Medicine and Cellular Longevity CrossRef
  7. DNA hypermethylation induced by Epstein-Barr virus in the development of Epstein-Barr virus-associated gastric carcinoma
    Su Jin Choi et al, 2017, Arch. Pharm. Res. CrossRef
  8. The risk of HCV infection among health-care workers and its association with extrahepatic manifestations
    Adriana Garozzo et al, 2017 CrossRef
  9. Lymphoepithelioma-like gastric carcinoma located in the lesser curvature of the gastric body: A case report and review of the literature
    QIUPING XU et al, 2016 CrossRef
  10. null
    Keisuke Matsusaka et al, 2017 CrossRef
  11. Anoikis resistance and oncoviruses
    Ehsan Kakavandi et al, 2017, J Cell Biochem CrossRef
  12. Iatrogenic solid tumors following immunosuppressive therapy
    Kossivi Dantey et al, 2017, Seminars in Diagnostic Pathology CrossRef
  13. null
    Alejandra Alarcón et al, 2017 CrossRef
  14. null
    P.D. Voyias et al, 2016 CrossRef
  15. The oncogenic role of Epstein-Barr virus-encoded microRNAs in Epstein-Barr virus-associated gastric carcinoma
    Jinglin Zhang et al, 2017, J. Cell. Mol. Med. CrossRef
  16. Role of viruses in gastrointestinal cancer
    Habibollah Mirzaei et al, 2017, J Cell Physiol CrossRef
  17. Clinical and pathological characterization of Epstein-Barr virus-associated gastric carcinomas in Portugal
    Joana Ribeiro et al, 2017, WJG CrossRef
  18. IFNγ induces PD-L1 overexpression by JAK2/STAT1/IRF-1 signaling in EBV-positive gastric carcinoma
    Ji Wook Moon et al, 2017, Sci Rep CrossRef
  19. An extremely rare case of Epstein-Barr virus-associated gastric carcinoma with differentiation to neuroendocrine carcinoma
    Ai Shimizu et al, 2017, Pathol Int CrossRef
  20. Aberrant expression of AID and AID activators of NF-κB and PAX5 is irrelevant to EBV-associated gastric cancers, but is associated with carcinogenesis in certain EBV-non-associated gastric cancers
    Takashi Mohri et al, 2017 CrossRef
  21. Viral Oncology: Molecular Biology and Pathogenesis
    Uyen Ngoc Mui et al, 2017, JCM CrossRef
  22. Outlooks on Ebstein-Barr Virus Associated Gastric Cancer
    Madiha Naseem et al, 2018, Cancer Treatment Reviews CrossRef
  23. Endoscopic and Immunohistochemical Characteristics of Gastric Cancer with versus without Helicobacter Pylori Eradication
    Masaaki Kodama et al, 2018, Digestion CrossRef
  24. null
    Irene Gullo et al, 2018 CrossRef
  25. New insights into the inflamed tumor immune microenvironment of gastric cancer with lymphoid stroma: from morphology and digital analysis to gene expression
    Irene Gullo et al, 2018, Gastric Cancer CrossRef
  26. null
    Qin Huang, 2018 CrossRef
  27. null
    Xiangshan Fan et al, 2018 CrossRef
  28. Risk factors for esophageal cancer: emphasis on infectious agents
    Hala El-Zimaity et al, 2018, Ann. N.Y. Acad. Sci. CrossRef
  29. Proposed Molecular and miRNA Classification of Gastric Cancer.
    Valli De re, 0 CrossRef
  30. EBV-associated lymphoepithelioma-like thyroid carcinoma with favorable outcome: case report with cytopathologic and histopathologic study
    Chih-Yi Liu et al, 2018, Diagn Pathol CrossRef
  31. null
    Masashi Fukayama et al, 2018 CrossRef
  32. Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions
    Francesca Battaglin et al, 2018, Cancer Cell Int CrossRef
  33. The Transcriptomic Landscape of Gastric Cancer: Insights into Epstein-Barr Virus Infected and Microsatellite Unstable Tumors
    Irene Gullo et al, 2018, IJMS CrossRef
  34. Epstein-Barr virus infection associated with pepsinogens and Helicobacter pylori infection in patients with gastric cancer
    Xuan Su et al, 2018, Virus Research CrossRef
  35. Infection-associated epigenetic alterations in gastric cancer: New insight in cancer therapy
    Sadegh Fattahi et al, 2018, J Cell Physiol CrossRef
  36. Expression of CCL21 by EBV-associated gastric carcinoma cells protects CD8+CCR7+ T lymphocytes from apoptosis via the mitochondria-mediated pathway
    Fang Tang et al, 2018, Pathology CrossRef
  37. The Predictive Value of Epstein-Barr Virus-Positivity in Patients Undergoing Gastrectomy Followed by Adjuvant Chemotherapy
    Dong Won Baek et al, 2018, Chonnam Med J CrossRef
  38. Clinicopathological features of 11 Epstein–Barr virus-associated intrahepatic cholangiocarcinoma at a single center in China
    Ke Sun et al, 2016, Medicine CrossRef
  39. Distribution of the Epstein-Barr virus in the normal stomach and gastric lesions in Thai population
    Supitcha Wanvimonsuk et al, 2018, J Med Virol CrossRef
  40. Types of Gastric Carcinomas
    Helge Waldum et al, 2018, IJMS CrossRef
  41. Ultrasonographic findings of intrahepatic lymphoepithelioma-like cholangiocarcinoma associated with Epstein–Barr virus
    Wenwu Ling et al, 2019, Medicine CrossRef
  42. Epstein–Barr Virus and Cancer
    Paul J. Farrell, 2019, Annu. Rev. Pathol. Mech. Dis. CrossRef
  43. Lack of association between Epstein–Barr virus and mammary tumours in dogs
    Gustavo A. Roa López et al, 2018 CrossRef
  44. Adenosine Induces EBV Lytic Reactivation through ADORA1 in EBV-Associated Gastric Carcinoma
    Su Choi et al, 2019, IJMS CrossRef
  45. Early Pattern of Epstein-Barr Virus Infection in Gastric Epithelial Cells by “Cell-in-cell”
    Wenxing Yue et al, 2019, Virol. Sin. CrossRef
  46. Overexpression and gene amplification of PD-L1 in cancer cells and PD-L1+ immune cells in Epstein–Barr virus-associated gastric cancer: the prognostic implications
    Ruri Saito et al, 2017, Mod Pathol CrossRef
  47. null
    Lara Alessandrini et al, 2019 CrossRef
  48. A protein and mRNA expression-based classification of gastric cancer.
    Namrata Setia et al, 2016, Mod Pathol CrossRef
  49. Loss of ARID1A expression predicts poor survival prognosis in gastric cancer: a systematic meta-analysis from 14 studies
    Lin Yang et al, 2016, Sci Rep CrossRef
  50. Current and Future Aspects of Immunotherapy for Esophageal and Gastric Malignancies
    Ramon Andrade De Mello et al, 2019, American Society of Clinical Oncology Educational Book CrossRef
  51. LMP2A induces DNA methylation and expression repression of AQP3 in EBV-associated gastric carcinoma
    Jiayi Wang et al, 2019, Virology CrossRef
  52. Assessing molecular subtypes of gastric cancer: microsatellite unstable and Epstein-Barr virus subtypes. Methods for detection and clinical and pathological implications
    Carolina Martinez-Ciarpaglini et al, 2019, ESMO Open CrossRef
  53. Are Epstein-Barr Virus-positive and -negative Gastric Carcinomas, With Lymphoid Stroma, Single Entity or Different Entities?
    Wei Kang et al, 2015, Clinical Gastroenterology and Hepatology CrossRef
  54. Prospective observation: Clinical utility of plasma Epstein–Barr virus DNA load in EBV‐associated gastric carcinoma patients
    Miao‐Zhen Qiu et al, 2019, Int. J. Cancer CrossRef
  55. Pathogenesis of Gastric Cancer
    Ceu Figueiredo et al, 2015, Helicobacter CrossRef
  56. Expression and prognostic roles of PIK3CA, JAK2, PD-L1, and PD-L2 in Epstein-Barr virus–associated gastric carcinoma
    Min Dong et al, 2016, Human Pathology CrossRef
  57. null
    Brian J. Czerniecki et al, 2016 CrossRef
  58. Clinicopathologic features of gastric carcinoma with lymphoid stroma in early gastric cancer
    Cheal Wung Huh et al, 2016, J. Surg. Oncol. CrossRef
  59. Frequent EBV positivity in conventional adenocarcinomas occurring simultaneously with EBV-associated gastric cancers
    Young-Bae Kim et al, 2016, Pathology CrossRef
  60. Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein-Barr virus status in a large cohort of gastric cancer patients.
    Akihito Kawazoe et al, 0 CrossRef
  61. Epstein–Barr virus gene expression and latency pattern in gastric carcinomas: a systematic review
    Joana Ribeiro et al, 2017, Future Oncology CrossRef
  62. Gastric Cancer in the Era of Precision Medicine.
    Xi Liu et al, 2017, Cell Mol Gastroenterol Hepatol CrossRef
  63. The Gastric Microbiome and Its Influence on Gastric Carcinogenesis
    Chao Zhang et al, 2017, Hematology/Oncology Clinics of North America CrossRef
  64. Clinical significance of spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia in Epstein-Barr virus–associated and Epstein-Barr virus–negative gastric cancer
    Yu Zhang et al, 2017, Human Pathology CrossRef
  65. Epstein-Barr virus infection induces genome-widede novoDNA methylation in non-neoplastic gastric epithelial cells
    Keisuke Matsusaka et al, 2017, J. Pathol CrossRef
  66. Transcriptome-wide analysis of alternative RNA splicing events in Epstein-Barr virus-associated gastric carcinomas
    Victoria E. S. Armero et al, 2017, PLoS ONE CrossRef
  67. null
    Shu Su et al, 2017 CrossRef
  68. Epstein-Barr virus infection as a predisposing factor for multiple sclerosis. An update from molecular biology, immunology and epidemiology
    David López-Valencia et al, 2019, Rev. Fac. Med. CrossRef
  69. Prevalence and characteristics of Epstein–Barr virus-associated gastric carcinomas in Portugal
    Célia Nogueira et al, 2017, Infect Agents Cancer CrossRef
  70. Thirty years of Epstein-Barr virus-associated gastric carcinoma
    Masashi Fukayama et al, 2019, Virchows Arch CrossRef
  71. Expression of LMP-1 protein in tumor cells and glandular epithelium of the peritumoral tissue in gastric cancer
    N. V. Danilova et al, 2019, Arkh. patol. CrossRef
  72. Aberrantly methylated-differentially expressed genes and pathways in Epstein–Barr virus-associated gastric cancer
    Jing-jing Jing et al, 2020, Future Oncology CrossRef
  73. Potential prognostic impact of EBV RNA‐seq reads in gastric cancer: a reanalysis of The Cancer Genome Atlas cohort
    Daichi Sadato et al, 2020, FEBS Open Bio CrossRef
  74. Epstein-Barr Virus miR-BART17-5p Promotes Migration and Anchorage-Independent Growth by Targeting Kruppel-Like Factor 2 in Gastric Cancer
    Jae Hee Yoon et al, 2020, Microorganisms CrossRef
  75. High Levels of Class I Major Histocompatibility Complex mRNA Are Present in Epstein–Barr Virus-Associated Gastric Adenocarcinomas
    Farhad Ghasemi et al, 2020, Cells CrossRef
  76. Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma
    Jie Xiong et al, 2020, Cancer Cell CrossRef
  77. Uterine cervical squamous cell carcinoma without p16 (CDKN2A) expression: Heterogeneous causes of an unusual immunophenotype
    Mariyo Rokutan‐Kurata et al, 2020, Pathology International CrossRef
  78. The impact of EBV on the epigenetics of gastric carcinoma
    Wen Liu et al, 2020, Future Virology CrossRef
  79. Differentiated tumor immune microenvironment of Epstein-Barr virus-associated and negative gastric cancer: implication in prognosis and immunotherapy.
    Jing Ma et al, 0 CrossRef
  80. The conundrum of the Epstein-Barr virus-associated gastric carcinoma in the Americas
    Gonzalo Carrasco-Avino et al, 2017, Oncotarget CrossRef
  81. Epstein-Barr virus BARF1-induced NFκB/miR-146a/SMAD4 alterations in stomach cancer cells
    Dong Ha Kim et al, 2016, Oncotarget CrossRef
  82. Association between Epstein-Barr virus infection and gastric cancer: a systematic review and meta-analysis
    Ahmad Tavakoli et al, 2020, BMC Cancer CrossRef
  83. Epstein–Barr virus-associated gastric cancer: disease that requires special approach
    Ekaterina Ignatova et al, 2020, Gastric Cancer CrossRef
  84. Gastrointestinal tissue‐based molecular biomarkers: a practical categorisation based on the 2019 World Health Organization classification of epithelial digestive tumours
    Javier I Quezada‐Marín et al, 2020, Histopathology CrossRef
  85. Observational cohort study of clinical outcome in Epstein–Barr virus associated gastric cancer patients
    Miao-Zhen Qiu et al, 2020, Ther Adv Med Oncol CrossRef
  86. A case of Epstein-Barr virus-associated carcinoma with lymphoid stroma
    Akie Sakakura et al, 2020, Prog. dig. Endosc CrossRef
  87. DNA Methylation Pattern of Early Genes of Epstein Barr Virus Associated With Gastric Carcinoma in Group of Iraqi Patients
    Hiba Sabah Jasim, 2019, J Pure Appl Microbiol CrossRef
  88. Use of immunotherapy in the treatment of gastric cancer (Review)
    Luhong Yang et al, 2019, Oncol Lett CrossRef
  89. Tumor microenvironment immune types in gastric cancer are associated with mismatch repair however, not HER2 status
    Anna Valentini et al, 2019, Oncol Lett CrossRef
  90. Lymphoepithelioma‑like gastric carcinoma treated with partial gastrectomy: Two case reports
    Huihua Cao et al, 2019, Oncol Lett CrossRef
  91. Actualización en cáncer gástrico. Nuevas clasificaciones moleculares
    Cristina Díaz del Arco et al, 2020, Revista Española de Patología CrossRef
  92. LncRNA IUR Is Downregulated in Gastric Carcinoma and Associated with Poor Survival
    Rui Ou et al, 2020, Cancer Biotherapy and Radiopharmaceuticals CrossRef
  93. Very low risk of lymph node metastasis in Epstein-Barr virus-associated early gastric carcinoma with lymphoid stroma
    Yuqing Cheng et al, 2020, BMC Gastroenterol CrossRef
  94. Homeobox proteins are potential biomarkers and therapeutic targets in gastric cancer: a systematic review and meta-analysis
    Xiao Jin et al, 2020, BMC Cancer CrossRef
  95. Analysis of clinicopathological and molecular features of crawling-type gastric adenocarcinoma
    Yasuko Fujita et al, 2020, Diagn Pathol CrossRef
  96. Epstein–Barr virus-associated gastric cancer: A distinct subtype
    Jing Yang et al, 2020, Cancer Letters CrossRef
  97. Robot-assisted laparoscopic total gastrectomy for Epstein–Barr virus-associated multiple gastric cancer: A case report
    Kotaro Kimura et al, 2020, International Journal of Surgery Case Reports CrossRef
  98. Status of kinases in Epstein-Barr virus and Helicobacter pylori Coinfection in gastric Cancer cells
    Charu Sonkar et al, 2020, BMC Cancer CrossRef
  99. Identification of subtype-specific genes signature by WGCNA for prognostic prediction in diffuse type gastric cancer
    Qi Zhou et al, 2020, Aging CrossRef
  100. Diagnosis of digestive system tumours
    Mary Kay Washington et al, 2020, Int. J. Cancer CrossRef
  101. Molecular portrait of stomach cancer associated with the Epstein–Barr virus
    E. O. Ignatova et al, 2020, Usp. mol. onkol CrossRef
  102. Expression of MAP9 in Epstein–Barr virus-associated gastric carcinoma
    Hua Xiao et al, 2020, Virus Research CrossRef
  103. Overview of Epstein-Barr-Virus-Associated Gastric Cancer Correlated with Prognostic Classification and Development of Therapeutic Options.
    Valli De re, 0 CrossRef
  104. Surgical treatment of Epstein-Barr virus–associated lymphoepithelioma-like carcinoma occurring in both the posterior mediastinum and liver
    Xiao-Hui Qian et al, 2020 CrossRef
  105. Alteration in stemness causes exclusivity between Epstein-Barr virus-positivity and microsatellite instability status in gastric cancer.
    Gyeong Hoon Kang, 0 CrossRef
  106. ARID1A deficiency in EBV-positive gastric cancer is partially regulated by EBV-encoded miRNAs, but not by DNA promotor hypermethylation
    Koji Kase et al, 2020 CrossRef
  107. Prevalence of HSV, Varicella-Zoster, CMV, EBV and HPV in the oral cavity and the larynx carcinoma in Iran
    Farnaz Dayyani et al, 2021, Future Virology CrossRef
  108. Ephrin receptor A2, the epithelial receptor for Epstein-Barr virus entry, is not available for efficient infection in human gastric organoids
    Nina Wallaschek et al, 2021, PLoS Pathog CrossRef
  109. EBV-miR-BART12 inhibits cell migration and proliferation by targeting Snail expression in EBV-associated gastric cancer
    Jun Li et al, 2021, Arch Virol CrossRef
  110. Identification of anti-epstein-barr virus (EBV) antibody signature in EBV-associated gastric carcinoma
    Lusheng Song et al, 2021, Gastric Cancer CrossRef
  111. Autophagy in Viral Development and Progression of Cancer
    Alejandra Suares et al, 2021, Front. Oncol. CrossRef
  112. Epstein-Barr Virus-associated Gastric Carcinoma
    Bong Eun Lee, 2021, Korean J Helicobacter Up Gastrointest Res CrossRef
  113. LMP2A suppresses the role of AHR pathway through ERK signal pathway in EBV-associated gastric cancer
    Yuanyuan Jiang et al, 2021, Virus Research CrossRef
  114. Serologically positive gastric cancers associated with Epstein-Barr virus
    I.I. Alentov et al, 2021, Profil. med. CrossRef
  115. Expression profiles of gastric cancer molecular subtypes in remnant tumors
    Marcus Fernando Kodama Pertille Ramos et al, 2021, WJGO CrossRef
  116. null
    Hugo Manuel Lopes de Sousa et al, 2021 CrossRef
  117. Subepithelial Tumor-like Gastric Cancer
    Kyoungwon Jung et al, 2021, Korean J Helicobacter Up Gastrointest Res CrossRef
  118. Pathogens and Carcinogenesis: A Review
    Muhammad Nur Adam Hatta et al, 2021, Biology CrossRef
  119. The promoter aberrant methylation status of TMEM130 is associated with gastric cancer
    Yan Zhang et al, 2021, Digestive and Liver Disease CrossRef
  120. Immune-Related Nine-MicroRNA Signature for Predicting the Prognosis of Gastric Cancer
    Jingxuan Xu et al, 2021, Front. Genet. CrossRef
  121. Landscape of EBV-positive gastric cancer
    Motonobu Saito et al, 2021, Gastric Cancer CrossRef
  122. Human Leukocyte Antigen Class I Deficiency in Gastric Carcinoma
    Akiko Iwasaki et al, 2021 CrossRef
  123. Metagenomic analysis of primary colorectal carcinomas and their metastases identifies potential microbial risk factors.
    Luigi Marongiu et al, 2021, Mol Oncol CrossRef
  124. Cisplatin Resistance in Epstein–Barr-Virus-Associated Gastric Carcinoma Acquired through ATM Methylation
    Sun Hee Lee et al, 2021, Cancers CrossRef
  125. Clinicopathological features of Epstein-Barr virus–associated superficial early stage gastric cancer treated with endoscopic submucosal dissection
    Yugo Suzuki et al, 2021, Digestive and Liver Disease CrossRef
  126. A STING inhibitor suppresses EBV‐induced B cell transformation and lymphomagenesis
    Shouhei Miyagi et al, 2021, Cancer Sci CrossRef
  127. Association of CLDN18 Protein Expression with Clinicopathological Features and Prognosis in Advanced Gastric and Gastroesophageal Junction Adenocarcinomas
    Antonio Pellino et al, 2021, JPM CrossRef
  128. Interdisciplinary insights into the link between gut microbiome and gastric carcinogenesis—what is currently known?
    Karolina Kaźmierczak-Siedlecka et al, 2021, Gastric Cancer CrossRef
  129. A case of Epstein Barr virus-associated primary squamous cell carcinoma of stomach
    Yuki Katsura et al, 2021, surg case rep CrossRef
  130. Oncogenic Viruses as Entropic Drivers of Cancer Evolution
    Italo Tempera et al, 2021, Front.Virol. CrossRef
  131. One stomach, two subtypes of carcinoma—the differences between distal and proximal gastric cancer
    Yuan Zhang et al, 2021 CrossRef
  132. Immune System Disorders, Cancer and Viral Infections: A New Treatment Opportunity for the Immune Checkpoint Inhibitors
    Alejandro Olivares-Hernández et al, 2021, Life CrossRef
  133. Molecular Pathogenesis, Targeted Therapies, and Future Perspectives for Gastric Cancer
    Yongji Zeng et al, 2021, Seminars in Cancer Biology CrossRef
  134. Microsatellite Instability, Epstein–Barr Virus, and Programmed Cell Death Ligand 1 as Predictive Markers for Immunotherapy in Gastric Cancer
    Hung-Yuan Yu et al, 2022, Cancers CrossRef
  135. A Network Pharmacology Perspective Investigation of the Pharmacological Mechanisms of the Herbal Drug FDY003 in Gastric Cancer
    Ho-Sung Lee et al, 2022, Natural Product Communications CrossRef
  136. Helicobacter pylori and Epstein-Barr Virus Co-Infection in Polish Patients with Gastric Cancer – A Pilot Study
    Magdalena Dzikowiec et al, 2022 CrossRef
  137. An Autopsy Case of Late-onset Fulminant Myocarditis Induced by Nivolumab in Gastric Cancer
    Ken Naganuma et al, 2022, Intern. Med. CrossRef
  138. DNA Methylation: An Important Biomarker and Therapeutic Target for Gastric Cancer
    Yunqing Zeng et al, 2022, Front. Genet. CrossRef
  139. PD-L1 expression in EBV associated gastric cancer: a systematic review and meta-analysis
    Áurea Lima et al, 2022, Discov Onc CrossRef
  140. Curcumin's prevention of inflammation-driven early gastric cancer and its molecular mechanism
    Wensen Zhang et al, 2022, Chinese Herbal Medicines CrossRef
  141. Viral and Clinical Oncology of Head and Neck Cancers
    Peter Goon et al, 2022, Curr Oncol Rep CrossRef
  142. Study of gastric adenocarcinomas association with the Epstein-Barr virus-encoded small RNAs
    N.V. Danilova et al, 2022, Arkh. patol. CrossRef
  143. LMP2A inhibits the expression of KLF5 through the mTORC1 pathway in EBV-associated gastric carcinoma
    Dandan Liu et al, 2022, Virus Research CrossRef
  144. Molecular Subtyping of Cancer Based on Robust Graph Neural Network and Multi-Omics Data Integration
    Chaoyi Yin et al, 2022, Front. Genet. CrossRef
  145. Características clínico-patológicas del adenocarcinoma gástrico asociado al virus de Epstein-Barr en una región de alta incidencia de cáncer gástrico en Colombia
    A. Vidal-Realpe et al, 2022, Revista de Gastroenterología de México CrossRef
  146. LMP1 Induces p53 Protein Expression via the H19/miR-675-5p Axis
    Jun Li et al, 2022, Microbiol Spectr CrossRef
  147. Sequence Variations of Epstein-Barr Virus-Encoded Small Noncoding RNA and Latent Membrane Protein 1 in Hematologic Tumors in Northern China
    Hai-Yu Wang et al, 2021, Intervirology CrossRef
  148. Inflammation and Gastric Cancer
    Aunchalee Jaroenlapnopparat et al, 2022, Diseases CrossRef
  149. Epstein-Barr Virus-Associated Gastric Carcinoma: Use of Host Cell Machineries and Somatic Gene Mutations.
    Hiroyuki Abe et al, 2015, Pathobiology CrossRef
  150. The Glypican-4 Gene Polymorphism rs1048369 and Susceptibility to Epstein-Barr Virus-Positive and -Negative Nasopharyngeal Carcinoma in Northern China.
    Shuzhen Liu et al, 2019, Oncol Res Treat CrossRef
  151. Clinical and pathologic characteristics of gastric adenocarcinoma associated with Epstein-Barr virus in a region with a high incidence of gastric cancer in Colombia
    A. Vidal-Realpe et al, 2022, Revista de Gastroenterología de México (English Edition) CrossRef
  152. Epstein–Barr virus and multiple sclerosis
    Samantha S. Soldan et al, 2022, Nat Rev Microbiol CrossRef
  153. Rate of Epstein-Barr Virus in Gastric Adenocarcinoma in Egyptian Patients in View of the WHO Classification and Correlation with p16 Immunoreactivity
    Safia Samir et al, 2022, Open Access Maced J Med Sci CrossRef
  154. Gastric cancer with Epstein-Barr virus heterogeneity: Evaluation of the frequency, clinicopathologic features, and genomic profiles
    Han-Na Kim et al, 2022, Pathology - Research and Practice CrossRef
  155. Molecular mechanism of aquaporin 3 (AQP3) regulating by LMP2A and its crosstalk with 4E-BP1 via ERK signaling pathway in EBV-associated gastric cancer
    Caixia Yu et al, 2022, Virus Research CrossRef
  156. Prediction of Epstein-Barr Virus Status in Gastric Cancer Biopsy Specimens Using a Deep Learning Algorithm
    Trinh Thi Le Vuong et al, 2022, JAMA Netw Open CrossRef
  157. Lymphoepithelioma-like cholangiocarcinoma not associated with Epstein–Barr virus or hepatitis virus: case report and literature review of 100 reported cases
    Yuki Adachi et al, 2022, Ther Adv Med Oncol CrossRef
  158. Analysis of the relationship between the expression of EBV-related antibodies and ET-1 axis in gastric cancer
    Yan Zhang et al, 2022, CBM CrossRef
  159. EBV persistence in gastric cancer cases conventionally classified as EBER-ISH negative
    M. C. Siciliano et al, 2022, Infect Agents Cancer CrossRef
  160. Epstein–Barr Virus (EBV) Epithelial Associated Malignancies: Exploring Pathologies and Current Treatments
    Oren Shechter et al, 2022, IJMS CrossRef
  161. PD-L1: Biological mechanism, function, and immunotherapy in gastric cancer
    Yingzi Zhang et al, 2022, Front. Immunol. CrossRef
  162. PD-L1 overexpression in EBV-positive gastric cancer is caused by unique genomic or epigenomic mechanisms
    Hiroshi Nakano et al, 2021, Sci Rep CrossRef
  163. Epstein‐Barr virus miR‐BART2‐5p and miR‐BART11‐5p regulate cell proliferation, apoptosis, and migration by targeting RB and p21 in gastric carcinoma
    Meng‐He Zhao et al, 2023, Journal of Medical Virology CrossRef
  164. Establishment and characterization of two Epstein–Barr virus‐positive gastric cancer cell lines with epitheliotropic M81 strain undergoing distinct viral and altered cellular expression profiles
    Mingqian Xu et al, 2023, Journal of Medical Virology CrossRef
  165. Map of thrombogenesis in viral infections and viral-driven tumours
    Beatriz Vieira Neto et al, 2023, Discov Onc CrossRef
  166. null
    Keerthana Raja et al, 2023 CrossRef
  167. Quantitative analysis of Epstein–Barr virus DNA in plasma and stomach biopsies of patients with gastric cancer
    Behrang Sarshari et al, 2023, Virus Genes CrossRef
  168. Assessing Epstein–Barr virus in gastric cancer: clinicopathological features and prognostic implications
    Guanghua Li et al, 2023, Infect Agents Cancer CrossRef
  169. Is There an Association between Concurrent Epstein–Barr Virus Infection and Sudden Hearing Loss?—A Case—Control Study in an East Asian Population
    Wei-Lun Lan et al, 2023, JCM CrossRef
  170. Gastric immune homeostasis imbalance: An important factor in the development of gastric mucosal diseases
    Shuhui Liu et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  171. Loss of viral genome with altered immune microenvironment during tumour progression of Epstein‐Barr virus ‐associated gastric carcinoma
    Atsushi Kondo et al, 2023, The Journal of Pathology CrossRef
  172. The EBV Gastric Cancer Resource (EBV-GCR): A Suite of Tools for Investigating EBV-Associated Human Gastric Carcinogenesis
    Mikhail Y. Salnikov et al, 2023, Viruses CrossRef
  173. null
    Fatemeh Abbaszadeh et al, 2023 CrossRef
  174. The Human Gastric Juice: A Promising Source for Gastric Cancer Biomarkers
    Nayra Felípez et al, 2023, IJMS CrossRef
  175. Oncogenic viruses and host lipid metabolism: a new perspective
    Zhiyuan Gong et al, 2023 CrossRef
  176. Differences in the Tumor Microenvironment of EBV-Associated Gastric Cancers Revealed Using Single-Cell Transcriptome Analysis
    Mikhail Y. Salnikov et al, 2023, Cancers CrossRef
  177. Exploring the link between viruses and cancer in companion animals: a comprehensive and comparative analysis
    Francesca Parisi et al, 2023, Infect Agents Cancer CrossRef
  178. Oncoviruses: How do they hijack their host and current treatment regimes
    Kainat Ahmed et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  179. MiR-BART1-3p and BART18-5p inhibit cell migration, proliferation and activate autophagy in Epstein-Barr virus-associated gastric cancer by targeting erythropoietin-producing human hepatocellular 2
    Duo Shi et al, 2023, Virus Genes CrossRef
  180. Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities
    Shivam Chowdhary et al, 2023, Mol. Pharmaceutics CrossRef
  181. Clinical outcomes of Epstein–Barr virus (EBV)-associated metastatic and locally advanced unresectable gastric cancers (GCs) in patients receiving first-line fluoropyrimidine and platinum (FP) doublet chemotherapy
    Eo Jin Kim et al, 2023, Gastric Cancer CrossRef
  182. FTO up‐regulation induced by MYC suppresses tumour progression in Epstein‒Barr virus‐associated gastric cancer
    Yun‐Yun Xu et al, 2023, Clinical & Translational Med CrossRef
  183. null
    Kazuki Kanayama et al, 2024 CrossRef
  184. null
    Chunguang Guo et al, 2023 CrossRef
  185. Recognizing the role of Epstein-Barr virus in gastric cancer: transcriptomic insights into malignancy modulation
    Tabassom Sedaghat Anbouhi et al, 2024, Virol J CrossRef
  186. The Role of LMP1 in Epstein-Barr Virus-associated Gastric Cancer
    Xinqi Huang et al, 2024, CCDT CrossRef
  187. The viral etiology of EBV-associated gastric cancers contributes to their unique pathology, clinical outcomes, treatment responses and immune landscape
    Mikhail Y. Salnikov et al, 2024, Front. Immunol. CrossRef
  188. Differential cytokine expression in gastric tissues highlights helicobacter pylori’s role in gastritis
    Xing-Tang Yang et al, 2024, Sci Rep CrossRef
  189. Viruses in glioblastoma: an update on evidence and clinical trials
    Bavani Gunasegaran et al, 2024, BJC Rep CrossRef
  190. Molecular classification and intratumoral heterogeneity of gastric adenocarcinoma
    Takeshi Kuwata, 2024, Pathology International CrossRef
  191. Prognostic Effect of Tertiary Lymphoid Structures in Epstein–Barr Virus–associated Gastric Carcinomas measured by Digital Image Analysis
    Yun Joo Cho et al, 2024, Laboratory Investigation CrossRef
  192. Clinicopathological characteristics and prognosis of Epstein-Barr virus–associated gastric cancer
    Lin-lin Li et al, 2024, Arch Virol CrossRef
  193. Research advances in the molecular classification of gastric cancer
    Dike Shi et al, 2024, Cell Oncol. CrossRef
  194. Histone methylation in Epstein–Barr virus-associated diseases
    Guanglian Chen et al, 2024, Epigenomics CrossRef